1. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. Issue 10 (October 2017) Authors: Yazici, Y.; McAlindon, T.E.; Fleischmann, R.; Gibofsky, A.; Lane, N.E.; Kivitz, A.J.; Skrepnik, N.; Armas, E.; Swearingen, C.J.; DiFrancesco, A.; Tambiah, J.R.S.; Hood, J.; Hochberg, M.C. Journal: Osteoarthritis and cartilage Issue: Volume 25:Issue 10(2017) Page Start: 1598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Issue 1 (January 2018) Authors: Deshmukh, V.; Hu, H.; Barroga, C.; Bossard, C.; KC, S.; Dellamary, L.; Stewart, J.; Chiu, K.; Ibanez, M.; Pedraza, M.; Seo, T.; Do, L.; Cho, S.; Cahiwat, J.; Tam, B.; Tambiah, J.R.S.; Hood, J.; Lane, N.E.; Yazici, Y. Journal: Osteoarthritis and cartilage Issue: Volume 26:Issue 1(2018) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as a potential treatment for degenerative disc disease. (April 2017) Authors: Barroga, C.; Deshmukh, V.; KC, S.; Dellamary, L.; Hood, J.; Steward, J.; Hu, H.; Yazici, Y. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Discovery of a Small Molecule Inhibitor of The Wnt Pathway (SM04755) as a Potential Topical Treatment for Tendinopathy. (April 2017) Authors: Deshmukh, V.; Seo, T.; Ibanez, M.; Hofilena, B.; KC, S.; Dellamary, L.; Stewart, J.; Hood, J.; Yazici, Y. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Isoform-selective PI3K inhibitors as novel therapeutics for the treatment of acute myocardial infarction. (20th March 2007) Authors: Doukas, J.; Wrasidlo, W.; Noronha, G.; Dneprovskaia, E.; Hood, J.; Soll, R. Journal: Biochemical Society transactions Issue: Volume 35:Number 2(2007) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment. Issue 9 (September 2019) Authors: Deshmukh, V.; O'Green, A.L.; Bossard, C.; Seo, T.; Lamangan, L.; Ibanez, M.; Ghias, A.; Lai, C.; Do, L.; Cho, S.; Cahiwat, J.; Chiu, K.; Pedraza, M.; Anderson, S.; Harris, R.; Dellamary, L.; KC, S.; Barroga, C.; Melchior, B.; Tam, B. Journal: Osteoarthritis and cartilage Issue: Volume 27:Issue 9(2019) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0069 Discovery of A Small Molecule Inhibitor of The WNT Pathway (SM04690) as A Potential Disease Modifying Treatment for Knee Osteoarthritis. (15th July 2016) Authors: Hood, J.; Barroga, C.; Hu, Y.; Deshmukh, V. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0428 Safety, Clinical and Imaging Outcomes of A Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in The Treatment of Osteoarthritis of The Knee: Exploratory Analysis of Results from A 24 Week, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study. (15th July 2016) Authors: Yazici, Y.; McAlindon, T.E.; Fleischmann, R.M.; Gibofsky, A.; Lane, N.E.; Kivitz, A.J.; Majumdar, S.; Strand, V.; Swearingen, C.J.; DiFrancesco, A.; Tambiah, J.; Hood, J.; Hochberg, M.C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 826 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The ULK1 inhibitor ENV-201 impairs tumor growth in KRAS-driven flank xenografts as a single agent and in combination with the KRAS inhibitor adagrasib. (October 2022) Authors: Pitman, J.; Dellamary, L.; Kc, S.; de los Rios, M.; Hood, J. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. What are the most needed new products to address AMR?. (December 2020) Authors: Hood, J.; Moutaftsi, M.; Mattar, C.; Edwards, S. Journal: International journal of infectious diseases Issue: Volume 101(2020)Supplement 1 Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗